ID   TNR6A_HUMAN             Reviewed;        1962 AA.
AC   Q8NDV7; C9JAR8; O15408; Q658L5; Q6NVB5; Q8NEZ0; Q8TBT8; Q8TCR0;
AC   Q9NV59; Q9P268;
DT   29-MAR-2005, integrated into UniProtKB/Swiss-Prot.
DT   18-MAY-2010, sequence version 2.
DT   20-JAN-2016, entry version 138.
DE   RecName: Full=Trinucleotide repeat-containing gene 6A protein;
DE   AltName: Full=CAG repeat protein 26;
DE   AltName: Full=EMSY interactor protein;
DE   AltName: Full=GW182 autoantigen;
DE            Short=Protein GW1;
DE   AltName: Full=Glycine-tryptophan protein of 182 kDa;
GN   Name=TNRC6A; Synonyms=CAGH26, KIAA1460, TNRC6;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), RNA-BINDING, TISSUE
RP   SPECIFICITY, SUBCELLULAR LOCATION, AND PHOSPHORYLATION.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=11950943; DOI=10.1091/mbc.01-11-0544;
RA   Eystathioy T., Chan E.K.L., Tenenbaum S.A., Keene J.D., Griffith K.,
RA   Fritzler M.J.;
RT   "A phosphorylated cytoplasmic autoantigen, GW182, associates with a
RT   unique population of human mRNAs within novel cytoplasmic speckles.";
RL   Mol. Biol. Cell 13:1338-1351(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Hughes-Davies L.;
RT   "Candidate EMSY interactor protein.";
RL   Submitted (JUN-2002) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3), AND NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 861-1962 (ISOFORM 6).
RC   TISSUE=Kidney, and Stomach;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Blocker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Kohrer K.,
RA   Ottenwalder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15616553; DOI=10.1038/nature03187;
RA   Martin J., Han C., Gordon L.A., Terry A., Prabhakar S., She X.,
RA   Xie G., Hellsten U., Chan Y.M., Altherr M., Couronne O., Aerts A.,
RA   Bajorek E., Black S., Blumer H., Branscomb E., Brown N.C., Bruno W.J.,
RA   Buckingham J.M., Callen D.F., Campbell C.S., Campbell M.L.,
RA   Campbell E.W., Caoile C., Challacombe J.F., Chasteen L.A.,
RA   Chertkov O., Chi H.C., Christensen M., Clark L.M., Cohn J.D.,
RA   Denys M., Detter J.C., Dickson M., Dimitrijevic-Bussod M., Escobar J.,
RA   Fawcett J.J., Flowers D., Fotopulos D., Glavina T., Gomez M.,
RA   Gonzales E., Goodstein D., Goodwin L.A., Grady D.L., Grigoriev I.,
RA   Groza M., Hammon N., Hawkins T., Haydu L., Hildebrand C.E., Huang W.,
RA   Israni S., Jett J., Jewett P.B., Kadner K., Kimball H., Kobayashi A.,
RA   Krawczyk M.-C., Leyba T., Longmire J.L., Lopez F., Lou Y., Lowry S.,
RA   Ludeman T., Manohar C.F., Mark G.A., McMurray K.L., Meincke L.J.,
RA   Morgan J., Moyzis R.K., Mundt M.O., Munk A.C., Nandkeshwar R.D.,
RA   Pitluck S., Pollard M., Predki P., Parson-Quintana B., Ramirez L.,
RA   Rash S., Retterer J., Ricke D.O., Robinson D.L., Rodriguez A.,
RA   Salamov A., Saunders E.H., Scott D., Shough T., Stallings R.L.,
RA   Stalvey M., Sutherland R.D., Tapia R., Tesmer J.G., Thayer N.,
RA   Thompson L.S., Tice H., Torney D.C., Tran-Gyamfi M., Tsai M.,
RA   Ulanovsky L.E., Ustaszewska A., Vo N., White P.S., Williams A.L.,
RA   Wills P.L., Wu J.-R., Wu K., Yang J., DeJong P., Bruce D.,
RA   Doggett N.A., Deaven L., Schmutz J., Grimwood J., Richardson P.,
RA   Rokhsar D.S., Eichler E.E., Gilna P., Lucas S.M., Myers R.M.,
RA   Rubin E.M., Pennacchio L.A.;
RT   "The sequence and analysis of duplication-rich human chromosome 16.";
RL   Nature 432:988-994(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4), AND NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 1515-1962.
RC   TISSUE=Kidney, and PNS;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RA   Gerhard D.S., Wagner L., Feingold E.A., Shenmen C.M., Grouse L.H.,
RA   Schuler G., Klein S.L., Old S., Rasooly R., Good P., Guyer M.,
RA   Peck A.M., Derge J.G., Lipman D., Collins F.S., Jang W., Sherry S.,
RA   Feolo M., Misquitta L., Lee E., Rotmistrovsky K., Greenhut S.F.,
RA   Schaefer C.F., Buetow K., Bonner T.I., Haussler D., Kent J.,
RA   Kiekhaus M., Furey T., Brent M., Prange C., Schreiber K., Shapiro N.,
RA   Bhat N.K., Hopkins R.F., Hsie F., Driscoll T., Soares M.B.,
RA   Casavant T.L., Scheetz T.E., Brown-stein M.J., Usdin T.B.,
RA   Toshiyuki S., Carninci P., Piao Y., Dudekula D.B., Ko M.S.,
RA   Kawakami K., Suzuki Y., Sugano S., Gruber C.E., Smith M.R.,
RA   Simmons B., Moore T., Waterman R., Johnson S.L., Ruan Y., Wei C.L.,
RA   Mathavan S., Gunaratne P.H., Wu J., Garcia A.M., Hulyk S.W., Fuh E.,
RA   Yuan Y., Sneed A., Kowis C., Hodgson A., Muzny D.M., McPherson J.,
RA   Gibbs R.A., Fahey J., Helton E., Ketteman M., Madan A., Rodrigues S.,
RA   Sanchez A., Whiting M., Madari A., Young A.C., Wetherby K.D.,
RA   Granite S.J., Kwong P.N., Brinkley C.P., Pearson R.L., Bouffard G.G.,
RA   Blakesly R.W., Green E.D., Dickson M.C., Rodriguez A.C., Grimwood J.,
RA   Schmutz J., Myers R.M., Butterfield Y.S., Griffith M., Griffith O.L.,
RA   Krzywinski M.I., Liao N., Morin R., Morrin R., Palmquist D.,
RA   Petrescu A.S., Skalska U., Smailus D.E., Stott J.M., Schnerch A.,
RA   Schein J.E., Jones S.J., Holt R.A., Baross A., Marra M.A., Clifton S.,
RA   Makowski K.A., Bosak S., Malek J.;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-157 (ISOFORM 5).
RC   TISSUE=Brain;
RX   PubMed=9225980; DOI=10.1007/s004390050476;
RA   Margolis R.L., Abraham M.R., Gatchell S.B., Li S.H., Kidwai A.S.,
RA   Breschel T.S., Stine O.C., Callahan C., McInnis M.G., Ross C.A.;
RT   "cDNAs with long CAG trinucleotide repeats from human brain.";
RL   Hum. Genet. 100:114-122(1997).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 565-1962.
RC   TISSUE=Brain;
RX   PubMed=10819331; DOI=10.1093/dnares/7.2.143;
RA   Nagase T., Kikuno R., Ishikawa K., Hirosawa M., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XVII.
RT   The complete sequences of 100 new cDNA clones from brain which code
RT   for large proteins in vitro.";
RL   DNA Res. 7:143-150(2000).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1522-1962.
RC   TISSUE=Ovarian carcinoma;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [9]
RP   AUTOANTIGENIC EPITOPE MAPPING.
RX   PubMed=14598044; DOI=10.1007/s00109-003-0495-y;
RA   Eystathioy T., Chan E.K.L., Takeuchi K., Mahler M., Luft L.M.,
RA   Zochodne D.W., Fritzler M.J.;
RT   "Clinical and serological associations of autoantibodies to GW bodies
RT   and a novel cytoplasmic autoantigen GW182.";
RL   J. Mol. Med. 81:811-818(2003).
RN   [10]
RP   SUBCELLULAR LOCATION.
RX   PubMed=13130130; DOI=10.1261/rna.5810203;
RA   Eystathioy T., Jakymiw A., Chan E.K.L., Seraphin B., Cougot N.,
RA   Fritzler M.J.;
RT   "The GW182 protein colocalizes with mRNA degradation associated
RT   proteins hDcp1 and hLSm4 in cytoplasmic GW bodies.";
RL   RNA 9:1171-1173(2003).
RN   [11]
RP   SUBCELLULAR LOCATION.
RX   PubMed=15494374; DOI=10.1242/jcs.01477;
RA   Yang Z., Jakymiw A., Wood M.R., Eystathioy T., Rubin R.L.,
RA   Fritzler M.J., Chan E.K.L.;
RT   "GW182 is critical for the stability of GW bodies expressed during the
RT   cell cycle and cell proliferation.";
RL   J. Cell Sci. 117:5567-5578(2004).
RN   [12]
RP   SUBCELLULAR LOCATION.
RX   PubMed=15908945; DOI=10.1038/ncb1265;
RA   Sen G.L., Blau H.M.;
RT   "Argonaute 2/RISC resides in sites of mammalian mRNA decay known as
RT   cytoplasmic bodies.";
RL   Nat. Cell Biol. 7:633-636(2005).
RN   [13]
RP   FUNCTION, INTERACTION WITH AGO2, AND SUBCELLULAR LOCATION.
RX   PubMed=16284623; DOI=10.1038/ncb1333;
RA   Liu J., Rivas F.V., Wohlschlegel J., Yates J.R. III, Parker R.,
RA   Hannon G.J.;
RT   "A role for the P-body component GW182 in microRNA function.";
RL   Nat. Cell Biol. 7:1261-1266(2005).
RN   [14]
RP   FUNCTION, INTERACTION WITH AGO2, ASSOCIATION WITH SIRNA, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=16284622; DOI=10.1038/ncb1334;
RA   Jakymiw A., Lian S.L., Eystathioy T., Li S., Satoh M., Hamel J.C.,
RA   Fritzler M.J., Chan E.K.L.;
RT   "Disruption of GW bodies impairs mammalian RNA interference.";
RL   Nat. Cell Biol. 7:1267-1274(2005).
RN   [15]
RP   ERRATUM.
RA   Jakymiw A., Lian S.L., Eystathioy T., Li S., Satoh M., Hamel J.C.,
RA   Fritzler M.J., Chan E.K.L.;
RL   Nat. Cell Biol. 8:100-100(2006).
RN   [16]
RP   SUBCELLULAR LOCATION, AND ASSOCIATION WITH MICRORNA.
RX   PubMed=16906129; DOI=10.1038/sj.embor.7400783;
RA   Pauley K.M., Eystathioy T., Jakymiw A., Hamel J.C., Fritzler M.J.,
RA   Chan E.K.L.;
RT   "Formation of GW bodies is a consequence of microRNA genesis.";
RL   EMBO Rep. 7:904-910(2006).
RN   [17]
RP   FUNCTION.
RX   PubMed=17671087; DOI=10.1101/gad.1566707;
RA   Wakiyama M., Takimoto K., Ohara O., Yokoyama S.;
RT   "Let-7 microRNA-mediated mRNA deadenylation and translational
RT   repression in a mammalian cell-free system.";
RL   Genes Dev. 21:1857-1862(2007).
RN   [18]
RP   ERRATUM.
RA   Wakiyama M., Takimoto K., Ohara O., Yokoyama S.;
RL   Genes Dev. 21:2509-2509(2007).
RN   [19]
RP   FUNCTION.
RX   PubMed=17596515; DOI=10.1091/mbc.E07-01-0070;
RA   Lian S.L., Fritzler M.J., Katz J., Hamazaki T., Terada N., Satoh M.,
RA   Chan E.K.L.;
RT   "Small interfering RNA-mediated silencing induces target-dependent
RT   assembly of GW/P bodies.";
RL   Mol. Biol. Cell 18:3375-3387(2007).
RN   [20]
RP   ERRATUM.
RA   Lian S.L., Fritzler M.J., Katz J., Hamazaki T., Terada N., Satoh M.,
RA   Chan E.K.L.;
RL   Mol. Biol. Cell 18:4200-4200(2007).
RN   [21]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=19056672; DOI=10.1242/jcs.036905;
RA   Li S., Lian S.L., Moser J.J., Fritzler M.L., Fritzler M.J., Satoh M.,
RA   Chan E.K.L.;
RT   "Identification of GW182 and its novel isoform TNGW1 as translational
RT   repressors in Ago2-mediated silencing.";
RL   J. Cell Sci. 121:4134-4144(2008).
RN   [22]
RP   IDENTIFICATION BY MASS SPECTROMETRY, AND INTERACTION WITH AGO2.
RX   PubMed=18690212; DOI=10.1038/nature07186;
RA   Qi H.H., Ongusaha P.P., Myllyharju J., Cheng D., Pakkanen O., Shi Y.,
RA   Lee S.W., Peng J., Shi Y.;
RT   "Prolyl 4-hydroxylation regulates Argonaute 2 stability.";
RL   Nature 455:421-424(2008).
RN   [23]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-1470, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [24]
RP   SUBCELLULAR LOCATION, AND INDUCTION.
RX   PubMed=18946079; DOI=10.1091/mbc.E08-08-0796;
RA   Jagannath A., Wood M.J.A.;
RT   "Localization of double-stranded small interfering RNA to cytoplasmic
RT   processing bodies is Ago2 dependent and results in up-regulation of
RT   GW182 and Argonaute-2.";
RL   Mol. Biol. Cell 20:521-529(2009).
RN   [25]
RP   FUNCTION, AND INTERACTION WITH AGO2.
RX   PubMed=19304925; DOI=10.1261/rna.1448009;
RA   Zipprich J.T., Bhattacharyya S., Mathys H., Filipowicz W.;
RT   "Importance of the C-terminal domain of the human GW182 protein TNRC6C
RT   for translational repression.";
RL   RNA 15:781-793(2009).
RN   [26]
RP   INTERACTION WITH AGO1; AGO2; AGO3 AND AGO4, SUBCELLULAR LOCATION, AND
RP   MUTAGENESIS OF TRP-313; TRP-345; TRP-370; TRP-420 AND TRP-483.
RX   PubMed=19324964; DOI=10.1261/rna.1229409;
RA   Lian S.L., Li S., Abadal G.X., Pauley B.A., Fritzler M.J.,
RA   Chan E.K.L.;
RT   "The C-terminal half of human Ago2 binds to multiple GW-rich regions
RT   of GW182 and requires GW182 to mediate silencing.";
RL   RNA 15:804-813(2009).
RN   [27]
RP   INTERACTION WITH AGO1; AGO2; AGO3 AND AGO4.
RX   PubMed=19383768; DOI=10.1261/rna.1606309;
RA   Lazzaretti D., Tournier I., Izaurralde E.;
RT   "The C-terminal domains of human TNRC6A, TNRC6B, and TNRC6C silence
RT   bound transcripts independently of Argonaute proteins.";
RL   RNA 15:1059-1066(2009).
RN   [28]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1585, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [29]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1869, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [30]
RP   INTERACTION WITH CNOT1.
RX   PubMed=21981923; DOI=10.1016/j.molcel.2011.09.007;
RA   Braun J.E., Huntzinger E., Fauser M., Izaurralde E.;
RT   "GW182 proteins directly recruit cytoplasmic deadenylase complexes to
RT   miRNA targets.";
RL   Mol. Cell 44:120-133(2011).
CC   -!- FUNCTION: Plays a role in RNA-mediated gene silencing by both
CC       micro-RNAs (miRNAs) and short interfering RNAs (siRNAs). Required
CC       for miRNA-dependent repression of translation and for siRNA-
CC       dependent endonucleolytic cleavage of complementary mRNAs by
CC       argonaute family proteins. As scaffoldng protein associates with
CC       argonaute proteins bound to partially complementary mRNAs and
CC       simultaneously can recruit CCR4-NOT and PAN deadenylase complexes.
CC       {ECO:0000269|PubMed:16284622, ECO:0000269|PubMed:16284623,
CC       ECO:0000269|PubMed:17596515, ECO:0000269|PubMed:17671087,
CC       ECO:0000269|PubMed:19056672, ECO:0000269|PubMed:19304925}.
CC   -!- SUBUNIT: Interacts with AGO1, AGO2, AGO3 and AGO4. Interacts with
CC       CNOT1; the interaction is direct and mediates the association with
CC       the CCR4-NOT complex. {ECO:0000269|PubMed:16284622,
CC       ECO:0000269|PubMed:16284623, ECO:0000269|PubMed:18690212,
CC       ECO:0000269|PubMed:19304925, ECO:0000269|PubMed:19324964,
CC       ECO:0000269|PubMed:19383768, ECO:0000269|PubMed:21981923}.
CC   -!- INTERACTION:
CC       Q9UL18:AGO1; NbExp=4; IntAct=EBI-2269715, EBI-527363;
CC       Q9UKV8:AGO2; NbExp=10; IntAct=EBI-2269715, EBI-528269;
CC       Q9H9G7:AGO3; NbExp=3; IntAct=EBI-2269715, EBI-2267883;
CC       Q9HCK5:AGO4; NbExp=4; IntAct=EBI-2269715, EBI-2269696;
CC       A5YKK6:CNOT1; NbExp=2; IntAct=EBI-2269715, EBI-1222758;
CC       Q58A45:PAN3; NbExp=2; IntAct=EBI-2269715, EBI-2513054;
CC       Q15645:TRIP13; NbExp=3; IntAct=EBI-2269715, EBI-358993;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, P-body
CC       {ECO:0000269|PubMed:11950943, ECO:0000269|PubMed:13130130,
CC       ECO:0000269|PubMed:15494374, ECO:0000269|PubMed:15908945,
CC       ECO:0000269|PubMed:16284622, ECO:0000269|PubMed:16284623,
CC       ECO:0000269|PubMed:16906129, ECO:0000269|PubMed:18946079,
CC       ECO:0000269|PubMed:19056672, ECO:0000269|PubMed:19324964}.
CC       Note=Mammalian P-bodies are also known as GW bodies (GWBs).
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=6;
CC       Name=1; Synonyms=TNGW1;
CC         IsoId=Q8NDV7-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8NDV7-2; Sequence=VSP_013294;
CC       Name=3;
CC         IsoId=Q8NDV7-3; Sequence=VSP_037287, VSP_037288, VSP_037289;
CC       Name=4;
CC         IsoId=Q8NDV7-4; Sequence=VSP_013292;
CC       Name=5;
CC         IsoId=Q8NDV7-5; Sequence=VSP_013295;
CC         Note=No experimental confirmation available.;
CC       Name=6;
CC         IsoId=Q8NDV7-6; Sequence=VSP_037288;
CC   -!- TISSUE SPECIFICITY: Ubiquitous. {ECO:0000269|PubMed:11950943}.
CC   -!- INDUCTION: By exogenous short interfering RNA (siRNA).
CC       {ECO:0000269|PubMed:18946079}.
CC   -!- MISCELLANEOUS: Antibodies against TNRC6A are found in sera from
CC       patients with Sjoegren syndrome (SS), ataxia and sensor neuropathy
CC       diseases that developed autoantibodies against protein of the GWB
CC       structure. Autoantibodies were mapped to the GW-rich mid-part, the
CC       non-GW-rich region and the C-terminus of the protein.
CC   -!- SIMILARITY: Belongs to the GW182 family. {ECO:0000305}.
CC   -!- SIMILARITY: Contains 1 RRM (RNA recognition motif) domain.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA91899.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=CAD28525.2; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY035864; AAK62026.1; -; mRNA.
DR   EMBL; AJ492221; CAD37348.1; -; mRNA.
DR   EMBL; AL713750; CAD28525.2; ALT_INIT; mRNA.
DR   EMBL; AL833757; CAH56236.1; -; mRNA.
DR   EMBL; AC002565; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC008731; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC024324; AAH24324.2; -; mRNA.
DR   EMBL; BC068209; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; U80739; AAB91438.1; -; mRNA.
DR   EMBL; AB040893; BAA95984.1; -; mRNA.
DR   EMBL; AK001773; BAA91899.1; ALT_INIT; mRNA.
DR   CCDS; CCDS10624.2; -. [Q8NDV7-1]
DR   RefSeq; NP_055309.2; NM_014494.2. [Q8NDV7-1]
DR   RefSeq; XP_005255311.1; XM_005255254.2. [Q8NDV7-6]
DR   RefSeq; XP_005255314.1; XM_005255257.3. [Q8NDV7-2]
DR   UniGene; Hs.655057; -.
DR   ProteinModelPortal; Q8NDV7; -.
DR   BioGrid; 118141; 25.
DR   DIP; DIP-54489N; -.
DR   DMDM; 296452846; -.
DR   MaxQB; Q8NDV7; -.
DR   PaxDb; Q8NDV7; -.
DR   PRIDE; Q8NDV7; -.
DR   Ensembl; ENST00000315183; ENSP00000326900; ENSG00000090905. [Q8NDV7-6]
DR   Ensembl; ENST00000395799; ENSP00000379144; ENSG00000090905. [Q8NDV7-1]
DR   GeneID; 27327; -.
DR   KEGG; hsa:27327; -.
DR   UCSC; uc002dmm.3; human. [Q8NDV7-1]
DR   UCSC; uc002dmn.3; human. [Q8NDV7-6]
DR   UCSC; uc002dmp.3; human. [Q8NDV7-3]
DR   UCSC; uc002dmr.3; human. [Q8NDV7-4]
DR   UCSC; uc010vcc.1; human. [Q8NDV7-2]
DR   CTD; 27327; -.
DR   GeneCards; TNRC6A; -.
DR   H-InvDB; HIX0012904; -.
DR   H-InvDB; HIX0173209; -.
DR   HGNC; HGNC:11969; TNRC6A.
DR   HPA; HPA015305; -.
DR   HPA; HPA017869; -.
DR   MIM; 610739; gene.
DR   neXtProt; NX_Q8NDV7; -.
DR   PharmGKB; PA36656; -.
DR   eggNOG; ENOG410IF5S; Eukaryota.
DR   eggNOG; ENOG41110AX; LUCA.
DR   GeneTree; ENSGT00410000025966; -.
DR   HOVERGEN; HBG062594; -.
DR   InParanoid; Q8NDV7; -.
DR   KO; K18412; -.
DR   OMA; RQNGNPS; -.
DR   PhylomeDB; Q8NDV7; -.
DR   TreeFam; TF329702; -.
DR   Reactome; R-HSA-1257604; PIP3 activates AKT signaling.
DR   Reactome; R-HSA-1912408; Pre-NOTCH Transcription and Translation.
DR   Reactome; R-HSA-2559580; Oxidative Stress Induced Senescence.
DR   Reactome; R-HSA-2559585; Oncogene Induced Senescence.
DR   Reactome; R-HSA-4086398; Ca2+ pathway.
DR   Reactome; R-HSA-426496; Post-transcriptional silencing by small RNAs.
DR   Reactome; R-HSA-5578749; Transcriptional regulation by small RNAs.
DR   Reactome; R-HSA-5687128; MAPK6/MAPK4 signaling.
DR   ChiTaRS; TNRC6A; human.
DR   GeneWiki; TNRC6A; -.
DR   GenomeRNAi; 27327; -.
DR   PRO; PR:Q8NDV7; -.
DR   Proteomes; UP000005640; Chromosome 16.
DR   Bgee; Q8NDV7; -.
DR   ExpressionAtlas; Q8NDV7; baseline and differential.
DR   Genevisible; Q8NDV7; HS.
DR   GO; GO:0000932; C:cytoplasmic mRNA processing body; IDA:MGI.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:HPA.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0035068; C:micro-ribonucleoprotein complex; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0000166; F:nucleotide binding; IEA:InterPro.
DR   GO; GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB.
DR   GO; GO:0009267; P:cellular response to starvation; IEA:Ensembl.
DR   GO; GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0010467; P:gene expression; TAS:Reactome.
DR   GO; GO:0035195; P:gene silencing by miRNA; IMP:BHF-UCL.
DR   GO; GO:0031047; P:gene silencing by RNA; TAS:Reactome.
DR   GO; GO:0045087; P:innate immune response; TAS:Reactome.
DR   GO; GO:0035278; P:negative regulation of translation involved in gene silencing by miRNA; IDA:UniProtKB.
DR   GO; GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0007219; P:Notch signaling pathway; TAS:Reactome.
DR   GO; GO:0048015; P:phosphatidylinositol-mediated signaling; TAS:Reactome.
DR   GO; GO:0035194; P:posttranscriptional gene silencing by RNA; TAS:Reactome.
DR   Gene3D; 3.30.70.330; -; 1.
DR   InterPro; IPR019486; Argonaute_hook_dom.
DR   InterPro; IPR012677; Nucleotide-bd_a/b_plait.
DR   InterPro; IPR000504; RRM_dom.
DR   InterPro; IPR032226; TNRC6_PABC-bd.
DR   Pfam; PF10427; Ago_hook; 1.
DR   Pfam; PF16608; TNRC6-PABC_bdg; 1.
**   PROSITE; PS00228; TUBULIN_B_AUTOREG; 1; FALSE_POS.
PE   1: Evidence at protein level;
KW   Alternative splicing; Coiled coil; Complete proteome; Cytoplasm;
KW   Phosphoprotein; Polymorphism; Reference proteome; RNA-binding;
KW   RNA-mediated gene silencing; Translation regulation.
FT   CHAIN         1   1962       Trinucleotide repeat-containing gene 6A
FT                                protein.
FT                                /FTId=PRO_0000081980.
FT   DOMAIN     1781   1853       RRM.
FT   REGION        1    932       Interaction with argonaute family
FT                                proteins.
FT   REGION      254    503       Sufficient for interaction with AGO1,
FT                                AGO3 and AGO4.
FT   REGION      270    346       Sufficient for interaction with AGO2.
FT   REGION      318    399       Sufficient for interaction with AGO2.
FT   REGION      340    439       Sufficient for interaction with AGO2.
FT   REGION      409    495       Sufficient for interaction with AGO2.
FT   REGION      502    751       Sufficient for interaction with AGO2.
FT   REGION      566   1343       Sufficient for interaction with AGO1 and
FT                                AGO4.
FT   REGION     1074   1144       Sufficient for interaction with AGO2.
FT   REGION     1604   1622       PABPC1-interacting motif-2 (PAM2).
FT   REGION     1670   1962       Sufficient for interaction with AGO2.
FT   COILED        7     54       {ECO:0000255}.
FT   COMPBIAS     93    127       Gln-rich.
FT   COMPBIAS    192    365       Ser-rich.
FT   MOD_RES    1470   1470       Phosphothreonine. {ECO:0000244|PubMed:
FT                                18669648}.
FT   MOD_RES    1585   1585       Phosphoserine. {ECO:0000244|PubMed:
FT                                19690332}.
FT   MOD_RES    1869   1869       Phosphoserine. {ECO:0000244|PubMed:
FT                                20068231}.
FT   VAR_SEQ       1   1801       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_013292.
FT   VAR_SEQ       1   1232       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:17974005}.
FT                                /FTId=VSP_037287.
FT   VAR_SEQ       1    253       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:11950943}.
FT                                /FTId=VSP_013294.
FT   VAR_SEQ       1     54       MRELEAKATKDVERNLSRDLVQEEEQLMEEKKKKKDDKKKK
FT                                EAAQKKATEQKIK -> MAYFGGTLYWLIFSTPFLLLGL
FT                                (in isoform 5). {ECO:0000303|PubMed:
FT                                9225980}.
FT                                /FTId=VSP_013295.
FT   VAR_SEQ    1280   1328       Missing (in isoform 3 and isoform 6).
FT                                {ECO:0000303|PubMed:17974005}.
FT                                /FTId=VSP_037288.
FT   VAR_SEQ    1611   1962       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:17974005}.
FT                                /FTId=VSP_037289.
FT   VARIANT     185    185       N -> K (in dbSNP:rs11639856).
FT                                /FTId=VAR_057251.
FT   VARIANT     592    592       A -> T (in dbSNP:rs6497759).
FT                                /FTId=VAR_057252.
FT   VARIANT     788    788       P -> S (in dbSNP:rs3803716).
FT                                /FTId=VAR_057253.
FT   VARIANT    1268   1268       E -> K (in dbSNP:rs2112782).
FT                                /FTId=VAR_057254.
FT   MUTAGEN     313    313       W->A: Does not impair interaction with
FT                                AGO2; when associated with A-345; A-370;
FT                                A-420 and A-483. {ECO:0000269|PubMed:
FT                                19324964}.
FT   MUTAGEN     345    345       W->A: Does not impair interaction with
FT                                AGO2; when associated with A-313; A-370;
FT                                A-420 and A-483. {ECO:0000269|PubMed:
FT                                19324964}.
FT   MUTAGEN     370    370       W->A: Does not impair interaction with
FT                                AGO2; when associated with A-313; A-345;
FT                                A-420 and A-483. {ECO:0000269|PubMed:
FT                                19324964}.
FT   MUTAGEN     420    420       W->A: Does not impair interaction with
FT                                AGO2; when associated with A-313; A-345;
FT                                A-370 and A-483. {ECO:0000269|PubMed:
FT                                19324964}.
FT   MUTAGEN     483    483       W->A: Does not impair interaction with
FT                                AGO2; when associated with A-313; A-345;
FT                                A-370 and A-420. {ECO:0000269|PubMed:
FT                                19324964}.
FT   CONFLICT     31     34       KKKK -> TEKE (in Ref. 2; CAD37348).
FT                                {ECO:0000305}.
FT   CONFLICT   1375   1375       V -> VV (in Ref. 3; CAD28525).
FT                                {ECO:0000305}.
FT   CONFLICT   1704   1704       S -> F (in Ref. 8; BAA91899).
FT                                {ECO:0000305}.
SQ   SEQUENCE   1962 AA;  210297 MW;  963C054628E18592 CRC64;
     MRELEAKATK DVERNLSRDL VQEEEQLMEE KKKKKDDKKK KEAAQKKATE QKIKVPEQIK
     PSVSQPQPAN SNNGTSTATS TNNNAKRATA NNQQPQQQQQ QQQPQQQQPQ QQPQPQPQQQ
     QPQQQPQALP RYPREVPPRF RHQEHKQLLK RGQHFPVIAA NLGSAVKVLN SQSESSALTN
     QQPQNNGEVQ NSKNQSDINH STSGSHYENS QRGPVSSTSD SSTNCKNAVV SDLSEKEAWP
     SAPGSDPELA SECMDADSAS SSESERNITI MASGNTGGEK DGLRNSTGLG SQNKFVVGSS
     SNNVGHGSST GPWGFSHGAI ISTCQVSVDA PESKSESSNN RMNAWGTVSS SSNGGLNPST
     LNSASNHGAW PVLENNGLAL KGPVGSGSSG INIQCSTIGQ MPNNQSINSK VSGGSTHGTW
     GSLQETCESE VSGTQKVSFS GQPQNITTEM TGPNNTTNFM TSSLPNSGSV QNNELPSSNT
     GAWRVSTMNH PQMQAPSGMN GTSLSHLSNG ESKSGGSYGT TWGAYGSNYS GDKCSGPNGQ
     ANGDTVNATL MQPGVNGPMG TNFQVNTNKG GGVWESGAAN SQSTSWGSGN GANSGGSRRG
     WGTPAQNTGT NLPSVEWNKL PSNQHSNDSA NGNGKTFTNG WKSTEEEDQG SATSQTNEQS
     SVWAKTGGTV ESDGSTESTG RLEEKGTGES QSRDRRKIDQ HTLLQSIVNR TDLDPRVLSN
     SGWGQTPIKQ NTAWDTETSP RGERKTDNGT EAWGSSATQT FNSGACIDKT SPNGNDTSSV
     SGWGDPKPAL RWGDSKGSNC QGGWEDDSAA TGMVKSNQWG NCKEEKAAWN DSQKNKQGWG
     DGQKSSQGWS VSASDNWGET SRNNHWGEAN KKSSSGGSDS DRSVSGWNEL GKTSSFTWGN
     NINPNNSSGW DESSKPTPSQ GWGDPPKSNQ SLGWGDSSKP VSSPDWNKQQ DIVGSWGIPP
     ATGKPPGTGW LGGPIPAPAK EEEPTGWEEP SPESIRRKME IDDGTSAWGD PSKYNYKNVN
     MWNKNVPNGN SRSDQQAQVH QLLTPASAIS NKEASSGSGW GEPWGEPSTP ATTVDNGTSA
     WGKPIDSGPS WGEPIAAASS TSTWGSSSVG PQALSKSGPK SMQDGWCGDD MPLPGNRPTG
     WEEEEDVEIG MWNSNSSQEL NSSLNWPPYT KKMSSKGLSG KKRRRERGMM KGGNKQEEAW
     INPFVKQFSN ISFSRDSPEE NVQSNKMDLS GGMLQDKRME IDKHSLNIGD YNRTVGKGPG
     SRPQISKESS MERNPYFDKD GIVADESQNM QFMSSQSMKL PPSNSALPNQ ALGSIAGLGM
     QNLNSVRQNG NPSMFGVGNT AAQPRGMQQP PAQPLSSSQP NLRAQVPPPL LSPQVPVSLL
     KYAPNNGGLN PLFGPQQVAM LNQLSQLNQL SQISQLQRLL AQQQRAQSQR SVPSGNRPQQ
     DQQGRPLSVQ QQMMQQSRQL DPNLLVKQQT PPSQQQPLHQ PAMKSFLDNV MPHTTPELQK
     GPSPINAFSN FPIGLNSNLN VNMDMNSIKE PQSRLRKWTT VDSISVNTSL DQNSSKHGAI
     SSGFRLEESP FVPYDFMNSS TSPASPPGSI GDGWPRAKSP NGSSSVNWPP EFRPGEPWKG
     YPNIDPETDP YVTPGSVINN LSINTVREVD HLRDRNSGSS SSLNTTLPST SAWSSIRASN
     YNVPLSSTAQ STSARNSDSK LTWSPGSVTN TSLAHELWKV PLPPKNITAP SRPPPGLTGQ
     KPPLSTWDNS PLRIGGGWGN SDARYTPGSS WGESSSGRIT NWLVLKNLTP QIDGSTLRTL
     CMQHGPLITF HLNLPHGNAL VRYSSKEEVV KAQKSLHMCV LGNTTILAEF ASEEEISRFF
     AQSQSLTPSP GWQSLGSSQS RLGSLDCSHS FSSRTDLNHW NGAGLSGTNC GDLHGTSLWG
     TPHYSTSLWG PPSSSDPRGI SSPSPINAFL SVDHLGGGGE SM
//
